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Background: More than 37 million people worldwide have been diagnosed with heart failure, which is a growing burden on
the health sector. Cardiac rehabilitation aims to improve patients’ recovery, functional capacity, psychosocial well-being, and
health-related quality of life. However, cardiac rehabilitation programs have poor compliance and adherence. Telerehabilitation
may be a solution to overcome some of these challenges to cardiac rehabilitation by making it more individualized. As part of
the Future Patient Telerehabilitation program, a digital toolbox aimed at enabling patients with heart failure to monitor and
evaluate their own current status has been developed and tested using data from a patient-reported outcome questionnaire that
the patient filled in every alternate week for 1 year.
Objective: The aim of this study is to evaluate the changes in quality of life and well-being among patients with heart failure,
who are participants in the Future Patient Telerehabilitation program over the course of 1 year.
Methods: In total, 140 patients were enrolled in the Future Patient Telerehabilitation program and randomized into either the
telerehabilitation group (n=70) or the control group (n=70). Of the 70 patients in the telerehabilitation group, 56 (80.0%) answered
the patient-reported outcome questionnaire and completed the program, and these 56 patients comprised the study population.
The patient-reported outcomes consisted of three components: (1) questions regarding the patients’ sleep patterns assessed using
the Spiegel Sleep Questionnaire; (2) measurements of physical limitations, symptoms, self-efficacy, social interaction, and quality
of life assessed using the Kansas City Cardiomyopathy Questionnaire in 10 dimensions; and (3) 5 additional questions regarding
psychological well-being that were developed by the research group.
Results: The changes in scores during 1 year of the study were examined using 1-sample Wilcoxon signed-rank tests. There
were significant differences in the scores for most of the slopes of the scores from the dimensions of the Kansas City
Cardiomyopathy Questionnaire (P<.05).
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Conclusions: There was a significant increase in clinical and social well-being and quality of life during the 1-year period of
participating in a telerehabilitation program. These results suggest that patient-reported outcome questionnaires may be used as
a tool for patients in a telerehabilitation program that can both monitor and guide patients in mastering their own symptoms.
Trial Registration: ClinicalTrials.gov NCT03388918; https://clinicaltrials.gov/ct2/show/NCT03388918
(JMIR Cardio 2021;5(2):e26544) doi: 10.2196/26544
KEYWORDS
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Introduction
Cardiovascular diseases are the leading cause of death
worldwide [1]. In 2016, cardiovascular diseases were the cause
of 31% of all deaths, which corresponded to 17.9 million people
[1]. More than 37 million people worldwide have been
diagnosed with heart failure (HF). Because of a poor prognosis,
a high risk of disadvantageous outcomes, and increasing
prevalence, HF is a growing burden on the health sector [2-4].
Cardiac rehabilitation aims to improve patients’ recovery,
functional capacity, psychosocial well-being, and health-related
quality of life. The rehabilitation process combines activities
such as physical activity, improved diet, weight control,
psychosocial coping, and disease management [5]. However,
cardiac rehabilitation programs have poor compliance and
adherence. Patients may have poor means of transport to the
rehabilitation facility, lack motivation, and feel that
rehabilitation activities are not sufficiently individualized; all
of these barriers negatively impact adherence to rehabilitation
programs, which may in turn exacerbate symptoms including
edema, fatigue, and shortness of breath, thus leading to
readmissions [5,6]. Telerehabilitation (TR) may be a solution
to overcome some of these challenges to cardiac rehabilitation
[7,8]. TR is defined as the delivery of rehabilitation services
through information and communication technologies [9].
TR may also be clinically relevant in obtaining health status
measures from the patients. In turn, these measures add
information regarding the severity of HF and may be used as
an aid for clinical management [10]. Patient-reported outcomes
(PROs) are clinical outcomes that increasingly focus on reducing
the disease burden and improving general well-being and
lifespan [11]. PRO can be used as a tool for screening and
monitoring symptoms and assessing the course of the disease
over time for clinicians to evaluate patient symptoms [12]. In
a PRO regime, the outcome of a treatment is directly
self-reported by the patient without registration or interpretation
by a clinician [11]. Some of the outcomes are measurements of
the patient’s symptoms and health-related quality of life, which
enable PROs to enhance targeted care and contribute to the
optimal use of health care resources [11]. In this study, PRO
from the Future Patient Telerehabilitation (FPT) program will
be made available to patients as a tool for empowering them
and increasing their knowledge of their own disease.
Through a user-driven innovation process, we have developed
the FPT program for patients with HF. The overall purpose of
the FPT program has been to increase the quality of life for
patients with HF and to educate the patients to perform
individualized monitoring to detect worsening of their own
symptoms, thereby avoiding rehospitalization [13]. As part of
the FPT program, a digital toolbox containing a PRO
questionnaire was created. The purpose of the digital toolbox
was to enable HF patients to monitor and evaluate their own
current status over the 1-year duration of the TR program, thus
enabling them to facilitate their contact with the hospital or their
consulting general practitioners. To our knowledge, no previous
studies that have investigated the clinical and psychological
value of PROs in TR for patients with HF. A review from 2016
[14] on the use of PRO instruments in HF management
concluded that the Minnesota Living with Heart Failure and
Kansas City Cardiomyopathy Questionnaire (KCCQ) were
useful PRO instruments in clinical care. However, more studies
are needed on the value and interpretability of PRO instruments
in clinical settings. The aim of this study is to evaluate the
changes in quality of life and well-being among patients with
HF, who are participants in the FPT program over the course
of 1 year [13].
Methods
Ethical Considerations
This study utilized data from an intervention group that received
TR (the TR group) in the FPT study, which was approved by
the North Denmark Region Committee on Health Research
Ethics (N-20160055) and the Danish Data Protection Agency.
The study is registered on ClinicalTrials.gov (NCT03388918).
The study was conducted in accordance with the tenets of the
Helsinki declaration, and all participants signed an informed
consent form prior to enrollment in the study.
Context and Intervention of the Study
The overall aim of the FPT study was to increase the quality of
life of patients with HF by training them to perform
individualized monitoring, which would enable to detect
worsening of their symptoms in a timely manner, thereby
avoiding rehospitalization [13]. The intervention of the FPT
was divided into three phases (Figure 1): (1) TR and titration
of medicine; as the adjustment of medication is specific to each
patient, this phase will last 0-3 months; (2) TR at home and at
a health care center or call center (3 months); and (3) follow-up
with TR in everyday life (6 months). The TR program was based
on a webpage called the HeartPortal [15], which is a digital
toolbox that functions as an interactive learning module. The
HeartPortal consists of (1) an information page containing text
and short videos, (2) a communication platform that helps
patients design their own TR plan and communicate directly
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with health care professionals, (3) visualization of measured
values, and (4) a PRO questionnaire to be answered every
second week. The measured values in HeartPortal included the
patients’ vital signs such as blood pressure, daytime and
nighttime pulse rates, weight, step count, respiration, and hours
of sleep. All data measured from the technologies were
transmitted by the patient to HeartPortal. The data are illustrated
as graphs and can be visualized and shared among patients, their
relatives, and health care professionals. Upon enrollment in the
study, the patients were instructed on how to use the PRO data
to monitor their own disease and how to take necessary action
if their symptoms worsened. The patients had the opportunity
to contact the TR coordinator of the FPT program regarding
any necessary action to be taken. Figure 2 shows the patients’
PRO data in graphical format over a period of 2 months. The
control group participated in the same 3 phases but without
participating in the TR program; that is, they had no access to
HeartPortal.
Figure 1. The 3 phases of the Future Patient Telerehabilitation study. PRO: patient-reported outcome.
Figure 2. A screen capture of HeartPortal. An illustration of the patient-reported outcome. Row 1: Information, My Treatment, My Status, Contacts,
and Questions; Row 2: Weight, Blood Pressure, Pulse, Breathing, Sleep, Steps, and Well-being; Row 3: Time Intervals (3 months, 6 months, and Entire
period); and Row 4 (bottom): Mood (light-green dot), Sleep (dark-green dot), Physical condition (orange dot), Symptom-free (red dot), Social contact
(blue dot), and Mean (blue line).
Participants
Participants were recruited from the cardiology wards at
hospitals in Skive, Viborg, Silkeborg, and Randers in Denmark.
Participants were recruited by a project nurse. The inclusion
criteria for the FPT were the following: patients with HF with
a New York Heart Association (NYHA) functional class of
I-IV, of whom a maximum of 20% of the patients were of
NYHA class I, ≥18 years of age, able to care for themselves,
and had basic computer skills.
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The sample size of the FPT study was determined to be 70
patients in each group (assuming a normal distribution), a power
of 80%, and a potential 10% dropout. This calculation was based
on the KCCQ guidelines, which state that a “moderate” level
of improvement is equal to a 10-point increase in the KCCQ
score [13,16]. In this study of the FPT program, only the KCCQ
outcomes from the intervention are reported. A comparison of
the KCCQ results from both the intervention and control groups
will be reported in a subsequent study on the evaluation of health
utilizations.
One Arm of a Randomized Controlled Trial
In total, 140 patients were enrolled in the FPT and randomized
into either the TR group (n=70) or the control group (n=70)
[13]. This study only reports the findings of the TR group. Of
the 70 patients in the TR group, 56 (80.0%) answered the PRO
questionnaire and completed the program, and these 56 patients
constituted the study population. The randomization and
follow-up procedure for the patients in the TR group are shown
in the CONSORT (Consolidated Standards of Reporting Trials)
diagram in Figure 3.
Figure 3. CONSORT (Consolidated Standards of Reporting Trials) diagram for the intervention group of the Future Patient Telerehabilitation trial.
Sociodemographic and Clinical Data
Sociodemographic data (age, gender, education, employment
status, and civil status) and clinical data (etiology of heart
failure, NYHA class, ejection fraction, weight, blood pressure,
and heart rate) were collected through self-reports or from the
electronic patient record.
PRO Measures
The PRO questionnaire consisted of components from three
questionnaires: (1) patients’ sleep quality was evaluated using
the Spiegel Sleep Questionnaire [17]; (2) physical limitations,
symptoms, self-efficacy, social interactions, and quality of life
were assessed using the validated KCCQ [16,18]; and (3)
psychological well-being was evaluated using 5 additional
questions developed by the research group.
Spiegel Sleep Questionnaire
Sleep quality was measured using the Spiegel Sleep
Questionnaire [17]. The questionnaire consists of 6 questions
regarding the patients’ sleep patterns and sleep quality, with all
items scored using a 5-point Likert scale. This is a validated
sleep questionnaire and has been used in clinical studies [17,19].
KCCQ
Measures of physical limitations, symptoms, self-efficacy, social
interaction, and quality of life were self-assessed using the
validated KCCQ. The KCCQ is a 23-item self-administered
questionnaire with 15 questions. All items are scored on a
5-7–point Likert scale. There are 5 individual subscales, all of
which, except for the self-efficacy subscale, are aggregated into
the clinical and overall summary scores. The total score of the
questionnaire is calculated by assigning an ordinal value to each
response, with 1 as the lowest value, and then adding the values
to obtain a scaled score for each domain. Accordingly, the scaled
scores range from 0 to 100, with a higher score indicating a
better health status, fewer symptoms, and increased quality of
life. Missing responses are assigned a value that corresponds
to an average of the answered items within the domain [16,20].
Psychological Well-being
The psychological well-being of the participants was measured
using 5 questions developed by the research group. The
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questions were validated for clarity and understanding among
patients with HF before use, in an iterative process. The
questions were answered using a visual analogue scale, with 0
being the lowest value and 9 being the highest value. The 5-item
psychological well-being scale was constructed on the basis of
5 different psychological aspects known to be of importance in
HF (depression, anxiety, positive affect, hopelessness, and social
support). We chose this approach, as it was not feasible to
measure these factors using 5 psychological questionnaires in
their entirety to measure these aspects. In addition, it has
previously been shown that it may be possible to assess some
of these factors through very brief questionnaires [21].
Furthermore, these questions were not intended as a means of
diagnosis, but rather as indications of the patients’psychological
status at the time of measurement.
Data Collection
All PRO questionnaire data were collected using Research
Electronic Data Capture platform (Vanderbilt University). The
questionnaires were made available on the internet to the patients
on HeartPortal twice a month (between days 10-14 and 24-28
of the month). If the patients did not answer the questionnaire,
the TR coordinator sent them a reminder.
Data Preprocessing
Data quality was ensured through data preprocessing. The time
points for the data were converted from dates to a numeric
variable—the questionnaire number. The PRO questionnaires
were available to the patients twice a month at the
aforementioned timepoints. Consequently, the questionnaires
were still available for responses during the entire period and
were not withdrawn after being completed by the patient. To
correct for multiple responses to the same timepoint, the first
responses within each time period were used in further analysis.
Statistical Analysis
Missing data were imputed by matching the responses from the
questionnaires answered to those closest to the timepoint of the
missing value [22]. Furthermore, our analyses showed that the
imputation strategy did not significantly alter the results (these
analyses are not included in this study). Nevertheless, missing
data constitute a noteworthy problem. Furthermore, to account
for missing data and varying durations of the 3 phases for the
individual subjects in the study, the differences in scores in the
3 phases have been compared with trends for the subjects
individually, in terms of slopes from linear regression analysis.
In addition, when calculating the results for each dimension of
the questionnaire, a minimum of half of the questions in each
dimension was required. If less than half of the questions were
answered, the results from that particular dimension would be
excluded from the analysis [22].
All preprocessing steps and data analysis were performed using
MATLAB (version R2019a, The MathWorks Inc). All statistical
analyses were performed using IBM SPSS Statistics (version
26, IBM Corp).
Prior to analysis, the data were examined for normality of their
distribution, using a Shapiro–Wilk test and by visual inspection
of scatter plots. The 3 different questionnaires, as well as the
subscales, comprising the PRO questionnaire in the FPT
program were analyzed individually. To enable comparisons
across subscales, scores were standardized by transforming each
subscale to a range of 0-100 with higher scores indicating better
health.
To evaluate changes in PROs during the 1-year duration of the
intervention, Friedman tests were used. In case of significance,
Wilcoxon sign-rank post hoc tests were used to determine in
which phase the differences occurred during the 1-year duration.
Results
Patient Characteristics
Table 1 shows the baseline sociodemographic and clinical
characteristics of patients in the TR group. These characteristics
are depicted as either the number of patients or as mean (SD)
values and ranges for the different parameters.
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Table 1. Clinical and sociodemographic data of the patients enrolled in the intervention group of the Future Patient Telerehabilitation program (N=67).
ValuesVariables
Age (years), mean (SD); range
62.18 (10.64); 35-81Men (n=51)
60.31 (11.31); 43-81Women (n=16)
61.73 (10.75); 35-81Men and women (n=67)
Clinical parameters, mean (SD); range
85.34 (20.35); 56-166Weight (kg)
124.42 (17.67); 84-172Systolic blood pressure (mmHg)
78.97 (10.99); 48-122Diastolic blood pressure (mmHg)
78.70 (17.76); 46-119Heart rate (beats/minute)
31.80 (8.49); 10-45Ejection fraction (%)









8 (11.4)Valvular heart disease
0 (0.0)Alcoholism
0 (0.0)Postpartum heart failure
0 (0.0)Chemotherapy
18 (26.9)Others
Marital status, n (%)
24 (35.8)Single or living alone
43 (64.2)Married or living with a partner








Employment status, n (%)
0 (0.0)Unemployed
19 (28.4)Sick leave
5 (7.5)Working for <20 hours/week
2 (2.9)Working for 20-36 hours/week
9 (13.4)Working full-time for 37 h/week
32 (47.8)Retired
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aSome patients have more causes of etiology of heart failure.
Well-being in the 3 Phases of the Study
The intervention in the FPT program was divided into 3 phases.
The mean participation times for the TR patients in each phase
were as follows: (1) TR and titration of medicine (2.37 months,
SD 1.72 months), (2) TR at home and at a health care center or
call center (3.43 months, SD 0.89 months), and (3) follow-up
with TR in everyday life (5.77 months, SD 1.00 month). The
patients completed 74.93% (SD 23.31%) of the total number
of questionnaires, with a minimum compliance of 14.81% and
a maximum compliance of 100%.
The Shapiro–Wilk test revealed that the data in the 13 different
dimensions of the questionnaire were not normally distributed.
Therefore, descriptive statistics for the data in 13 dimensions
are presented in Table 2 as median (IQR) scores.
Changes in the median scores from each dimension for the 3
phases are illustrated in Figure 4. The dotted lines in Figure 4
demarcate the 3 phases. Each line in Figure 4, within each phase,
represents 1 of the 13 dimensions of the questionnaires. As such,
Figure 4 illustrates the trend within each of the 3 phases and
serves as a visual presentation of the data, showing that all 3
phases have an increasing slope. Based on the changes in the
median scores shown in Figure 4, we observed a trend that
indicates that the scores increased for most of the dimensions
during the 3 phases, most notably in phase 1.
Changes in PRO scores across the 3 phases of the study were
examined using Friedman tests. As shown in Table 3, there
were significant differences in scores on most of the dimensions
in the KCCQ (P<.05) during the 1-year intervention. Wilcoxon
signed-rank post hoc tests were performed to examine the
differences identified by the Friedman tests. These results are
presented in Table 4 as z scores, which are standardized scores
that indicate the difference between preintervention and
postintervention scores of the measure in question. As such, a
negative z score indicates a positive change over time (median
scores for each phase are provided in Table 2). However, since
no significant differences were observed across phases 2 and
3, these results are not shown.
Table 2. Median (IQR) scores for all patient-reported outcome measures.
Median (IQR) score
in all phases (n=56)
Median (IQR) score
in phase 3 (n=56)
Median (IQR) score
in phase 2 (n=62)
Median (IQR) score
in phase 1 (n=67)
DimensionQuestionnaire
58.33 (12.50)57.20 (12.50)58.33 (12.50)58.33 (12.50)SleepSpiegel Sleep Questionnaire
28.89 (5.28)28.89 (6.67)28.89 (6.67)28.89 (8.89)Psychological well-
being
Psychological well-being
Kansas City Cardiomyopathy Questionnaire
88.75 (29.17)91.67 (29.17)87.50 (26.56)79.17 (31.25)Physical limitations
50.00 (0.00)50.00 (0.00)50.00 (0.00)50.00 (0.00)Symptom stability
82.81 (36.98)83.33 (37.76)77.60 (35.94)79.17 (37.50)Symptom frequency
83.33 (31.25)83.33 (35.42)75.00 (25.00)75.00 (3.50)Symptom burden
82.81 (33.20)83.33 (34.90)78.39 (30.99)76.04 (34.37)Total symptom score
75.00 (25.00)75.00 (25.00)75.00 (25.00)75.00 (25.00)Self-efficacy
83.33 (33.33)83.33 (32.29)75.00 (35.42)66.67 (3.33)Quality of life
81.25 (37.50)83.85 (33.33)80.21 (32.29)66.67 (46.88)Social limitation
79.75 (30.21)82.58 (31.48)77.34 (33.28)72.14 (32.42)Overall summary
score
85.02 (30.14)86.98 (32.03)79.82 (24.90)76.04 (27.08)Clinical summary
score
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Figure 4. Changes in median scores from the 13 dimensions of the questionnaires. Dotted lines indicate a change in phase in the Future Patient
Telerehabilitation program.
Table 3. Results of the Friedman test of the individual dimensions during 1 year.
Changes in score over timeDimensionQuestionnaire
P valueχ2 (df)
.930.14 (2)Sleep qualitySpiegel Sleep Questionnaire
.980.04 (2)Psychological well-beingPsychological well-being





<.001a17.18 (2)Total symptom score
.124.32 (2)Self-efficacy
.02a7.54 (2)Quality of life
<.001a19.75 (2)Social limitation
.001a14.71 (2)Overall summary score
<.001a19.54 (2)Clinical summary score
aStatistically significant at P<.05 (2-tailed).
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Table 4. z scores and significance levels from the Wilcoxon signed-rank post hoc tests when testing for differences in trends on the Kansas City
Cardiomyopathy Questionnaire in terms of slopes between the phases.
SlopesDimension
Phase I vs phase IIIPhase I vs phase II









aStatistically significant at P<.05.
bHigher slopes in phase I.
Discussion
Principal Findings
In the FPT program, the PRO questionnaire has served as a tool
for patients on HeartPortal to help themselves monitor their
well-being. The aim of this study was to evaluate the changes
in quality of life and well-being for patients with HF who are
participants in the FPT program over a 1-year period. We found
that during the 1-year intervention, the following dimensions
showed an increase in their median scores: physical limitation,
symptom frequency, total symptom score, quality of life, social
limitation, overall summary score, and clinical summary score.
These changes were significantly different for most of the
change in scores over time from the dimensions from the KCCQ.
In Figure 4, the increase in scores appeared more pronounced
in the first phase, where patients start their TR and have their
medication adjusted, compared to phases II (TR at home and
rehabilitation at a health care center) and III (TR at home and
follow-up in everyday life). However, patient scores increased
continuously throughout all phases. This suggests that the
intervention is most effective in phase I, as patients in this initial
phase will tend to be more open-minded and motivated for
changing their lifestyle and using the digital toolbox to empower
themselves. As such, our results support the notion that
rehabilitation should be initiated as soon as possible, preferably
as part of the initial treatment phase, when patients are most
motivated to initiate such changes. An analysis of the changes
in scores during a year of TR showed significant differences in
the scores on all dimensions of the KCCQ, except for
self-efficacy. In general, these findings indicate that almost all
scores from the different dimensions showed an increase and a
significant difference for the overall change during 1 year of
the intervention, thus indicating an improvement in the patients’
health. We have not identified other studies reporting this type
of improvement by using PRO questionnaires.
PRO questionnaires are normally used as a tool for research.
They enable clinicians to obtain a better understanding of the
patients’ health status and serve as a clinical management tool
[10]. In the FPT program, we deployed PRO as a tool for
patients to monitor their own disease during their rehabilitation
process. The patients answered almost 75% of all questionnaires
for a period of 1 year, thus indicating a high degree of
compliance with the PRO tool on HeartPortal. A study in
Denmark [23] on HF and PRO has reported a compliance rate
of approximately 50%. In this study, however, the PRO
questionnaire was used by patients to document their symptoms
prior to visiting the HF outpatient clinic at the hospital. Thus,
PRO served as a tool for clinicians as well [23]. This active use
of PRO data by patients may help explain the high compliance
rate in our FPT program. To our knowledge, no other TR studies
have allowed for the possibility of evaluating the current status
of patients with HF during 1 year with the use of PRO measures.
Our data analysis has thus demonstrated that the PRO
questionnaire can provide a cross-sectional view of the
development of the patients’ well-being and quality of life. The
increase in the scores over time may indicate that the patients
have used the PRO questionnaire to become more aware of their
own symptoms and, therefore, be better equipped to navigate
and cope with HF in their everyday lives. We have explored
how patients have used the PRO questionnaire in the digital
toolbox during their participation in the FPT program. This will
be further documented in a subsequent study that describes
patients’ qualitative perspectives of using PRO as a part of TR.
A new study by Butler et al [24] in 2020 suggests that changes
even smaller than 5-point improvements in KCCQ scores may
be clinically significant. In the FPT study, the median (IQR) of
the KCCQ clinical summary score increased from 76.04 (IQR
27.08) in phase I to 86.98 (IQR 32.03) in phase III, yielding a
total median increase of more than 10 points. This indicates that
the change in scores has clinical relevance, thereby indicating
improvements in health based on the KCCQ results. However,
no change was observed in the median scores of the Spiegel
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Sleep Questionnaire or the psychological well-being
questionnaire. However, the FPT program was not designed to
provide a specialized psychological intervention for
psychological distress, such as anxiety and depression, but
followed general guidelines for identifying and treating
psychological distress in patients with HF.
Limitations
This study has limitations that should be considered. First, the
timing of the PRO questionnaires may have been too frequent.
In this study, it was collected every second week during 1 year,
and this may have resulted in some patients skipping some of
the questionnaires, thereby resulting in missing data. However,
as some of the questionnaires referred to the patients’perceived
symptoms over the previous 2 weeks, we considered this a
relevant timeframe to detect changes in symptoms. Moreover,
the responses from the PRO questionnaire provide subjective
cross-sectional insights into the patients’ well-being, which
should be taken into consideration when evaluating their general
well-being and when used in a clinical setting. In future studies,
technological opportunities for mandatory responses may be
used to generate more complete data from all participants.
It would have been valuable to include data from the control
group for comparison. This study compared individual data
over time, which is a valuable approach in identifying a trend.
Nevertheless, on the basis of the available data, it was not
possible to assess the development in quality of life and clinical
aspects within the control group.
Conclusions
There was a significant increase in clinical and social well-being
and quality of life during 1 year of participating in the TR
program. These results suggest that PRO questionnaires may
be used as a tool for patients in a TR program that can both
monitor and guide the patients in mastering their own symptoms,
improving their own well-being in a TR program, and enhancing
their recovery.
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